Reexamining Ophthalmic Drugs, Safety and Tolerability in Phase 1 Clinical Trials-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Reexamining Ophthalmic Drugs, Safety and Tolerability in Phase 1 Clinical Trials

Published:2021-10 Issue: Volume:Volume 17 Page:1123-1134
ISSN:1178-203X
Container-title:Therapeutics and Clinical Risk Management
language:en
Short-container-title:TCRM

Author:

Muñoz-Villegas Patricia^ORCID,Navarro-Sánchez Andrea A.,Sánchez-Ríos Alejandra,Olvera-Montaño Oscar^ORCID,Baiza-Durán Leopoldo M.

Publisher

Informa UK Limited

Subject

Chemical Health and Safety,Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,Safety Research,General Medicine

Reference29 articles.

1. Psychological Status of Volunteers in a Phase I Clinical Trial Assessed by Symptom Checklist 90 (SCL-90) and Eysenck Personality Questionnaire (EPQ)

2. To report or not to report: Exploring healthy volunteers' rationales for disclosing adverse events in Phase I drug trials

3. Adverse drug reactions: definitions, diagnosis, and management

4. Risks of phase I research with healthy participants: A systematic review

5. Phase 1 Clinical Trials of a Selective Rho Kinase Inhibitor, K-115

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and tolerability of pooled human immune globulins after topical ophthalmic administration in New Zealand White rabbits;Cutaneous and Ocular Toxicology;2024-07-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP